Arthur F. Ryan - 01 Feb 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Feb 2022
Net transactions value
-$60,714
Form type
4
Filing time
02 Feb 2022, 15:16:48 UTC
Previous filing
05 Jan 2022
Next filing
03 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,202 -2 -0.01% $600.89 22,580 01 Feb 2022 Direct F1
transaction REGN Common Stock Sale $602 -1 -0% $601.79 22,579 01 Feb 2022 Direct F1
transaction REGN Common Stock Sale $7,831 -13 -0.06% $602.35 22,566 01 Feb 2022 Direct F1, F2
transaction REGN Common Stock Sale $3,622 -6 -0.03% $603.61 22,560 01 Feb 2022 Direct F1, F3
transaction REGN Common Stock Sale $604 -1 -0% $604.26 22,559 01 Feb 2022 Direct F1
transaction REGN Common Stock Sale $4,238 -7 -0.03% $605.50 22,552 01 Feb 2022 Direct F1, F4
transaction REGN Common Stock Sale $12,135 -20 -0.09% $606.74 22,532 01 Feb 2022 Direct F1, F5
transaction REGN Common Stock Sale $1,823 -3 -0.01% $607.56 22,529 01 Feb 2022 Direct F1, F6
transaction REGN Common Stock Sale $609 -1 -0% $608.74 22,528 01 Feb 2022 Direct F1
transaction REGN Common Stock Sale $21,942 -36 -0.16% $609.50 22,492 01 Feb 2022 Direct F1, F7
transaction REGN Common Stock Sale $3,051 -5 -0.02% $610.17 22,487 01 Feb 2022 Direct F1, F8
transaction REGN Common Stock Sale $3,057 -5 -0.02% $611.33 22,482 01 Feb 2022 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 13 shares of Company stock on February 1, 2022 at prices ranging from $602.09 to $602.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2022 at prices ranging from $603.06 to $603.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2022 at prices ranging from $605.19 to $605.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 20 shares of Company stock on February 1, 2022 at prices ranging from $606.07 to $606.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2022 at prices ranging from $607.46 to $607.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 36 shares of Company stock on February 1, 2022 at prices ranging from $609.00 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2022 at prices ranging from $610.02 to $610.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2022 at prices ranging from $611.06 to $611.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price.